2BB score and signals
Quince Therapeutics, Inc.’s current 2BB score is 0 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 1 | Very Weak |
| Quality | 60 | Strong |
| Risk | 66 | High |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 2012 |
| Employees | 38 |
| 52-week range | $15.10 – $909.98 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -1.1492 | — | $0.00 |
| 2026-08-10 | — | -18.2376 | — | $0.00 |
| 2026-05-11 | — | -2.6112 | — | $0.00 |
| 2026-04-10 | -7.1 | -1.9258 | $0.00 | $0.00 |
